Plerixafor Plus G-CSF for Mobilization and Collection of Peripheral Hematopoietic Stem Cells
Lymphoma
Enrolment: 32 · Results not recorded
Loading the evidence…
Biologic · Cell therapy (PBMCs mobilised by alpha-tocopherol succinate and AMD3100/plerixafor); mobilization component (plerixafor) is clinically used
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Lymphoma
Enrolment: 32 · Results not recorded
Blood And Marrow Transplantation
Enrolment: 22 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Whole body gamma irradiation at a high dose; exact dose not stated in abstract
Infusion of alpha-tocopherol succinate and AMD3100 mobilised peripheral blood mononuclear cells inhibited apoptosis, increased cell proliferation in intestine and spleen and reduced bacterial translocation compared with vehicle-mobilised cells.
Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.